Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The effectiveness of sofosbuvir and daclatasvir in the treatment of hepatitis C in thalassaemia major patients and their effect on haematological factors.

Indian journal of medical microbiology - 1 Jan 2000

Zamani Farhad, Ajdarkosh Hossein, Safarnezhad-Tameshkel Fahimeh, Azarkeivan Azita, Keyvani Hossein, Naserifar Farshad, Vafaeimanesh Jamshid

Abstract excerpt

Context: Patients with thalassaemia are at risk of infections such as hepatitis C virus (HCV) due to their repeated blood transfusions; meanwhile, the treatment of thalassaemia patients who had developed HCV infection is a controversial issue. Aims: Although the effectiveness of direct-acting antivirals on HCV infection has been confirmed, their side-effects as well as effects on haematological factors due to the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to beta-Thalassemia
Share to Carbamates

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Therapy, Combination

Share to Hepatitis C

Share to Imidazoles

Share to Pyrrolidines

Share to Sofosbuvir

Share to Valine

Source

Identifiers

PMID: 30084415
DOI: 10.4103/ijmm.IJMM_18_90

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The effectiveness of sofosbuvir and daclatasvir in the treatment of hepatitis C in thalassaemia major patients and their effect on haematological factors.PMID 30084415Read ↗

Effectiveness And Safety Of Direct Acting Antiviral Agents In Thalassaemic Patients With Chronic Hepatitis C.Semantic proximity Read ↗

Sofosbuvir/Ledipasvir for Treatment of Chronic Hepatitis C Infection in Adult Patients with β- Thalassemia Major: A Real-Life Study.Semantic proximity Read ↗

Randomised clinical trial: sofosbuvir and ledipasvir in patients with transfusion-dependent thalassaemia and HCV genotype 1 or 4 infection.Semantic proximity Read ↗

Treatment of chronic hepatitis C in polytransfused thalassaemic patients: a meta-analysis.Semantic proximity Read ↗

Hemoglobin Decrease with Iron Deficiency Induced by Daclatasvir plus Asunaprevir Combination Therapy for Chronic Hepatitis C Virus Genotype 1b.Semantic proximity Read ↗

Treatment of chronic hepatitis C in sickle cell disease and thalassaemic patients with interferon and ribavirin.Semantic proximity Read ↗

Post-transfusion hepatitis C virus infection among β-thalassaemic individuals with associated clinical parameters.Semantic proximity Read ↗

Interferon and ribavirin as frontline treatment for chronic hepatitis C infection in thalassaemia major.Semantic proximity Read ↗

Treatment of hepatitis C virus infection with direct-acting antiviral agent-based regimens in Iranian patients with hereditary bleeding disorders.Semantic proximity Read ↗

Efficacy and safety of interferon-based therapy in the treatment of adult thalassemic patients with chronic hepatitis C: a 12 years audit.Semantic proximity Read ↗

Peg-interfon alpha-2a and low-dose ribavirin for treatment of hepatitis C virus infection in patients with sickle-cell anemia in Saudi Arabia.Semantic proximity Read ↗

Distribution of hepatitis C virus genotype in Iranian multiply transfused patients with thalassemia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.